Brain zap test may tailor ADHD meds for kids
NCT ID NCT04421248
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to see if two brain measurements taken with Transcranial Magnetic Stimulation (TMS) can help guide ADHD treatment in children aged 8 to 12. Researchers will test these measurements for reliability, how they change with a single dose of methylphenidate (Ritalin), and how they relate to thinking and emotion. The goal is to develop a tool that could lead to more personalized and effective ADHD care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Methylphenidate (Ritalin)
- What this could lead to
- If successful, this could lead to a brain-based test to help doctors choose the best ADHD treatment for each child, improving outcomes.
- What could go wrong
- This is an early-phase biomarker study, not a treatment trial. The TMS measures may not reliably predict treatment response, and results may not apply to all children with ADHD.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATTENTION DEFICIT HYPERACTIVITY DISORDER COMBINED are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Cincinnati Children's Hospital Medical Center
RECRUITINGCincinnati, Ohio, 45229, United States
-
Kennedy Krieger Institute
RECRUITINGBaltimore, Maryland, 21205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.